These include: Nausea (very common, affecting more than 1 in 10 people) Diarrhoea, constipation, or vomiting Abdominal pain or bloating Reduced appetite (this is part of the therapeutic effect) These symptoms typically improve over time as your body adjusts to the medication
It can be safe when prescribed appropriately, but like all GLP-1 medications, it may cause side effects such as nausea or digestive discomfort
Taste changes
This gives your body time to adjust to the medication gradually
These suppliers can legally sell Retatrutide and similar peptides labeled strictly for research, laboratory, or investigational use
While these trials were not specifically designed to assess joint pain, patients with obesity-related joint pain who achieve significant weight loss through GLP-1 therapy often report improved mobility, reduced need for analgesics, and enhanced ability to engage in physical activitycreating a positive cycle of further weight management and joint health